Stay updated with breaking news from Jonathan Jorgl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This year’s proxy season saw a significant increase in the number of companies rejecting director nominations by dissident stockholders due to purported non-compliance with the...
The number of shareholder proposals put forward in 2022 increased by roughly 9% over 2021. At the same time, however, the number of shareholder proposals put forward by hedge funds...
The number of shareholder proposals put forward in 2022 increased by roughly 9% over 2021. At the same time, however, the number of shareholder proposals put forward by hedge funds and...
NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Jonathan Jorgl, an AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) stockholder, together with his nominees,...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires